1.361
price up icon1.57%   0.021
 
loading

Finanzdaten der Medicinova Inc-Aktie (MNOV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.1346
- - - -
Operating Expenses
16.84%
3.7417
3.2025 3.3091 3.0465 3.136
Benefits Costs and Expenses
100.00%
-
6.2799 - - -
Costs And Expenses
47.41%
3.7417
2.5382 - - -
Operating Income/Loss
12.63%
-3.6071
-3.2025 -3.3091 -3.0465 -3.136
Income/Loss From Continuing Operations Before Tax
104.70%
0.1346
-2.8641 -2.8522 -2.6282 -2.7545
Income/Loss From Continuing Operations After Tax
14.56%
-3.2812
-2.8641 -2.8522 -2.6282 -2.7545
Net Income/Loss
14.56%
-3.2812
-2.8641 -2.8522 -2.6282 -2.7545
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
49.05
49.05 49.05 49.05 49.05
Diluted Average Shares
0.00%
49.05
49.05 49.05 49.05 49.05
Basic Earnings Per Share
16.67%
-0.07
-0.06 -0.06 -0.05 -0.06
Diluted Earnings Per Share
16.67%
-0.07
-0.06 -0.06 -0.05 -0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.11
price up icon 1.60%
$84.09
price down icon 0.61%
$25.20
price up icon 1.91%
$102.39
price down icon 0.60%
$135.82
price up icon 1.13%
biotechnology ONC
$299.30
price down icon 0.28%
Kapitalisierung:     |  Volumen (24h):